Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Catalyst Pharmaceutical Partners Raises $6 Mln In Registered Direct Offering

Catalyst Pharmaceutical Partners Inc. (CPRX: Quote) has reached definitive agreements to sell 4.0 million common shares, and common stock purchase warrants to buy an aggregate of 1.2 million shares, in a registered direct public offering. The aggregate offering price for each share and corresponding warrant is $1.50, resulting in gross proceeds of $6 million.

The common stock purchase warrants have a five year-term and an exercise price of $2.08 per share. The offering may close on or about August 31, 2012. Catalyst expects to use the net proceeds from this offering to fund costs associated with the company's product development efforts and for general corporate purposes. Roth Capital Partners has acted as the exclusive placement agent for the transaction.

Click here to receive FREE breaking news email alerts for Catalyst Pharmaceutical Partners Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Google and Microsoft are opposing a petition by hoteliers such as Marriott International the right to block personal Wi-Fi on their premises. Elon Musk, the CEO of electric car maker Tesla Motors Inc (TSLA), on Christmas announced an upcoming upgrade for Tesla Roadster that will improve its mile-range to about 400 miles. "Roadster upgrade will enable non-stop travel from LS to SF -- almost 400 mile range. Details tmrw. Merry Christmas!,"... United Parcel Service Inc. (UPS) said Friday that it expects consumers will ship more than 800,000 packages back to retailers and merchants on January 6, 2015, or the UPS National Returns Day. By the end of the first full week in January, the package delivery giant expects to transport 4 million return...
comments powered by Disqus